- £14.09m
- £10.40m
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Total Revenue | 0 | 0 | 0 | 0 | 0 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 2.22 | 0.699 | 0.359 | 0.905 | 0.706 |
Operating Profit | -2.22 | -0.699 | -0.359 | -0.905 | -0.706 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -2.21 | -0.698 | -0.359 | -0.788 | -0.506 |
Provision for Income Taxes | |||||
Net Income After Taxes | -2.21 | -0.698 | -0.359 | -0.788 | -0.506 |
Net Income Before Extraordinary Items | |||||
Net Income | -2.21 | -0.698 | -0.359 | -0.788 | -0.506 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -2.21 | -0.698 | -0.359 | -0.788 | -0.506 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.006 | -0.001 | -0.001 | -0.001 | -0.001 |